$14.45
0.574.11%
Last update: Oct 27, 4:15 AM
Biohaven Ltd (BHVN) Stock Price, Quote, News & History
BHVNNYSE
FDA accepts Biohaven's Vyglxia NDA resubmission for SCA with a Q1 2027 goal date, planning an advisory committee review.
You can purchase shares of Biohaven (NYSE:BHVN) through any online brokerage.
Other companies in Biohaven’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Biohaven has a consensus price target of $33.44.
The stock price for Biohaven (NYSE: BHVN) is $14.4997 last updated October 27, 2026 at 4:15 AM EDT.
There are no upcoming dividends for Biohaven.
Biohaven does not have any upcoming earnings scheduled.
There is no upcoming split for Biohaven.
Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline...
